News

O.D. Notebook: Reduce the Cycle of Worry

Practice Tip: Develop healthy habits that reduce the cycle of worry. One such habit: Stay active. Specifically, each morning, write your goals for the day, and keep your mind and actions focused on those goals. For additional habits, visit “CEO Challenge” at https://www.optometricmanagement.com/issues/2020/may-2020/leading-off-ceo-challenge-create-habits-that-reduc
 
Association News
  •   American Academy of Optometry Foundation has announced the recipients of the 2020 Johnson & Johnson Vision Award of Excellence in Contact Lens Patient Care Grants, which recognizes outstanding fourth-year student clinicians who have demonstrated skillful knowledge of the contact lens field. Each winner receives a $500 educational award and a personalized plaque commemorating their accomplishment. For the full list of winners, visit  
    https://www.aaopt.org/home/aaof/news-detail/2020/05/09/american-academy-of-optometry-foundation-is-pleased-to-announce-the-2020-johnson-johnson-award-of-excellence-in-contact-lens-patient-care-grant-recipients .
  •  The AOA will hold a Virtual Learning Livecast, June 24 to June 27, during which O.D.s paraoptometric staff and students can earn four days of CE credits and professional development hours. The topics: Infection control, Tele-optometry, Systemic diseases, Coding, Artificial intelligence, Low vision, Eye diseases and clinical practice guidelines and a COPE-approved ePoster session. Visit AOA 2020 Virtual Learning for additional information. You can also contact EducationCenter@aoa.org with any questions.
  •  SECO International’s online education arm, SECO University isoffering LIVE Event Distance Learning CE through the SECO-U webinar series, which is ARBO-approved as live CE. The program includes the one-hour CE live webinar “The Disease of Myopia and Strategies for Myopia Control,” scheduled for May 14 at 8:00. The cost of participation is $20 per hour and is not included in subscriber plans.For registration information, visit http://secouniversity.com/webinar-series/
  • The Vision Council released data that shows the percentage of consumers reporting that they will postpone or cancel eyewear purchases has been declining at a slightly more accelerated rate over the last three weeks, dropping from 38% to 25% over that time. Additionally, more ECPs are reporting being open to the public in the wake of the COVID-19 pandemic. This corresponds with an increase in business performance, with 19% of ECPs reporting unchanged or increased capture rate, compared with 14% the previous week, The Vision Council says.  
Company News
  • Heidelberg Engineering awarded Prof. John M. Nolan, of the Nutrition Research Centre Ireland, School of Health Science, Waterford Institute of Technology (Ireland), the Heidelberg Engineering Xtreme Research Award for his research related to macular pigment for vision health and function, as well as for his recent work on how to use macular pigment as a biomarker for brain nutrition and its connection to cognitive function and Alzheimer’s disease. Prof. Nolan has standardized these measurements with an investigational SPECTRALIS Macular Pigment Optical Volume. (The device is currently under development.)
  • MedOp Health, Inc., has announced the launch of MaxiVision Immune Boost, a scientifically formulated supplement designed to support immune defense. The amounts of the four ingredients — zinc, selenium, vitamin C and vitamin D — were carefully proportioned to match those in published clinical studies. Eye care professionals can call (888) 577-4165 for more information. 
  • Oyster Point Pharma, Inc. has announced positive top-line results from the Phase 3 ONSET-2 study in dry eye disease. Specifically, the trial met the primary endpoint, where a greater percentage of subjects treated with Oyster’s 0.6 mg/ml and 1.2 mg/ml of OC-01 nasal spray gained >10 mm on Schirmer’s score compared to control. Additionally, key secondary endpoints were met, including an improvement in eye dryness score in the normal clinic environment, as well as mean change in Schirmer’s score in the 1.2 mg/ml dose group. The overall safety profile of OC-01 nasal spray was “found to be consistent with prior data without any new safety signals,” the company says.
  • TearLab Corporation has announced it has entered into a definitive agreement pursuant to which Accelmed Partners II (AP-II) will acquire TearLab. In connection with the acquisition, AP-II has agreed to an investment of $25 million over two tranches that will occur in conjunction with the company delisting from the “over the counter” OTCQB market, and TearLab and its senior secured lender, CR Group, has agreed to restructure the terms of the company’s outstanding senior secured indebtedness. Post transaction, TearLab will be a private company and AP-II will be the controlling shareholder. Proceeds from the AP-II investment will be used to pay down a portion of TearLab’s existing debt, and fund both organic and inorganic growth opportunities. 
  • Valley Contax, a custom contact lens manufacturer, recently released its new Boost Marketing Program that includes several media options, such as patient guides, social media posts, magazine ads, videos and more, most of which can be customized with the practice name, logo, photos and other information. There’s no cost to order for qualified Custom Stable fitters. Practitioners can learn more about Valley Contax and the Boost Marketing Program by visiting valleycontax.com
Product News
  • Clariti 1 day toric contact lenses, from CooperVision, are now available in axes in the -2.25 cylinder power, and plus powers are immediately available for shipment. The lenses are manufactured using a high-precision, automated process and provide rotational stability, with nearly 100 percent of lenses stabilizing within 10° or less from the optimum position within three minutes of dispensing, the company says. 
 
O.D. Notebook is published weekly on Wednesdays. Unless otherwise noted, the information presented is based on press releases. Find earlier editions here. To submit a press release to be considered for publication, click here. Additionally, find frequently updated COVID-19 coverage here.